(Q43760540)

English

Total plasma homocysteine and related amino acids in end-stage renal disease (ESRD) patients measured by gas chromatography-mass spectrometry--comparison with the Abbott IMx homocysteine assay and the HPLC method

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Total plasma homocysteine and related amino acids in end-stage renal disease (ESRD) patients measured by gas chromatography-mass spectrometry--comparison with the Abbott IMx homocysteine assay and the HPLC method (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

1 reference

based on heuristic

inferred from title

author name string

J I Sigit

1

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

M Hages

2

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

K A Brensing

3

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

U Frotscher

4

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

K Pietrzik

5

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

K von Bergmann

6

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

D Lütjohann

7

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

publication date

1 August 2001

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Clinical Chemistry and Laboratory Medicine

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

39

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

8

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

681-690

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

describes a project that uses

gas chromatography-mass spectrometry

1 reference

based on heuristic

inferred from title

Clinical chemistry and molecular biology of homocysteine metabolism: an update

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2001.112

21 January 2018

Recent data are not in conflict with homocysteine as a cardiovascular risk factor

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2001.112

21 January 2018

Plasma homocysteine concentrations and risk of coronary heart disease in UK Indian Asian and European men.

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2001.112

21 January 2018

Kinetic basis of hyperhomocysteinemia in patients with chronic renal failure.

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2001.112

21 January 2018

Homocysteine and cardiovascular disease

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2001.112

21 January 2018

No net renal extraction of homocysteine in fasting humans

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2001.112

21 January 2018

Hyperhomocysteinemia and traditional cardiovascular disease risk factors in end-stage renal disease patients on dialysis: a case-control study

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2001.112

21 January 2018

Hyperhomocyst(e)inemia and the prevalence of atherosclerotic vascular disease in patients with end-stage renal disease

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2001.112

21 January 2018

Elevation of total homocysteine in the serum of patients with cobalamin or folate deficiency detected by capillary gas chromatography-mass spectrometry

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2001.112

21 January 2018

A novel fluorogenic reagent for thiols: ammonium 7-fluorobenzo-2-oxa-1,3-diazole-4-sulfonate

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2001.112

21 January 2018

Assay of methylmalonic acid in the serum of patients with cobalamin deficiency using capillary gas chromatography-mass spectrometry

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2001.112

21 January 2018

A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2001.112

21 January 2018

Identifiers

10.1515/CCLM.2001.112

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43760540&oldid=2103104516"